Key result
Central fat, particularly visceral adipose tissue, was the most significant correlate of cardiometabolic risk, accounting for 27% of the variance in insulin resistance.
Why the study?
To investigate the relationship between body fat distribution and cardiometabolic risk in mixed-ancestry South African men and women, and explore the effect of menopausal status in women.
Cross-Sectional (n=253)
No
Central fat is the most significant correlate of cardiometabolic risk, while lower body fat is associated with reduced risk in mixed-ancestry South African adults, with relationships influenced by gender and menopausal status.
Answers are grounded in this paper and cite their sources.
Central fat links to higher cardiometabolic risk in mixed-ancestry SA adults; leaves open sex- and menopause-specific screening implications pending prospective data.
OBJECTIVE: To investigate the relationship between body fat distribution and cardiometabolic risk in mixed-ancestry South African (SA) men and women, and to explore the effect of menopausal status on these relationships in women. METHODS: In a cross-sectional study, 207 mixed-ancestry SA women and 46 men underwent measurement of body composition using dual-energy X-ray absorptiometry, blood pressure, oral glucose tolerance, lipid profile and high-sensitivity C-reactive protein determination. The associations between different body fat compartments and associated cardiometabolic risk factors were explored. The association between fat mass and regional subcutaneous adipose tissue and cardiometabolic risk factors differed by gender and menopausal status. CONCLUSIONS: Central fat was the most significant correlate of cardiometabolic risk and lower body fat was associated with reduced risk. These relationships were influenced by gender and menopausal status.
No takes yet. Share an insight, caveat, or question.
Davidson et al. (2019) conducted a cross-sectional in Cardiometabolic risk (n=253). Body fat distribution (visceral adipose tissue) was evaluated on Variance in insulin resistance (HOMA-IR) explained by visceral adipose tissue (VAT) (R2 = 0.27). Central fat, particularly visceral adipose tissue, was the most significant correlate of cardiometabolic risk, accounting for 27% of the variance in insulin resistance.
Synapse has enriched 10 related papers. Consider them for comparative context: